Latest news
Amgen (AMGN) Is Up 6.7% After EMA Backs Broader Repatha Use in High-Risk Patients – Has The Bull Case Changed? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 11:36:46 GMTMRA Advisory Group Grows Holdings in Amgen Inc. $AMGN - MarketBeatMarketBeat · Sat, 08 Aug 2026 10:37:41 GMTTeamwork Financial Advisors LLC Sells 8,835 Shares of Amgen Inc. $AMGN - MarketBeatMarketBeat · Sat, 08 Aug 2026 09:51:29 GMTAmanda Pullinger: Key Insights from Amgen’s 2026 Advocacy Summit - OncodailyOncodaily · Sat, 08 Aug 2026 08:17:37 GMTAbner Herrman & Brock LLC Decreases Stock Holdings in Amgen Inc. $AMGN - MarketBeatMarketBeat · Sat, 08 Aug 2026 07:09:18 GMTAmgen (NASDAQ:AMGN) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:23:47 GMTAmgen SVP & CCO Nancy Grygiel disposes of $1.19m in stock - Investing.comInvesting.com · Sat, 08 Aug 2026 00:19:49 GMTBob Bradway: Amgen Reports 10% Revenue Growth in Q2 2026 - OncodailyOncodaily · Fri, 07 Aug 2026 19:08:36 GMT